Blvr Valves denied as non-formulary by Humana?

Humana's specific coverage criteria for blvr valves are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied BLVR Valves as "Non-Formulary" — and What This Really Means

Bronchoscopic lung volume reduction (BLVR) valves are a medical device/procedure — not a pharmaceutical — so a strict "non-formulary" denial in the drug-formulary sense is unusual. When Humana issues this type of denial for BLVR, it typically reflects one of two situations: (1) the benefit is classified under a device or procedure benefit category that requires coverage determination approval and was not pre-authorized under the applicable benefit structure, or (2) a claims-processing system error applied a formulary exclusion code that was intended for a drug, not a procedure. In either case, the denial is frequently correctable.

The first step is to identify exactly what Humana means by "non-formulary" in your denial letter — specifically, which benefit category or coverage determination it relies on. This shapes whether your appeal is a benefit-classification argument or a straightforward coverage dispute.

## Your Federal Appeal Rights

ACA §2719 and ERISA §503 protect your right to internal appeal and, after an adverse internal decision, to binding external review by an Independent Review Organization (IRO). You have up to 180 days from the denial notice to file an internal appeal, and generally four months after the final internal denial to request IRO external review. Expedited review is available when delay would seriously jeopardize your health.

## Documentation to Gather

• Denial letter and EOB: Read the specific language Humana used. Note the denial code and any benefit-category reference. This tells you whether you are dealing with a coding error, a benefit-structure issue, or a coverage determination.
• Plan documents: Obtain your Summary Plan Description (SPD) or Evidence of Coverage (EOC). Review how medical procedures and devices are covered — look for respiratory disease, pulmonary procedures, or durable medical equipment sections. If BLVR is not explicitly excluded, it may be covered as a medical/surgical benefit.
• Prescriber letter: A letter from the treating pulmonologist explaining the clinical necessity of the procedure and citing the FDA clearance of the valve system — reinforcing that this is an established, approved medical procedure.
• FDA clearance documentation: Attach the FDA authorization for the valve system to counter any suggestion the device is unapproved or experimental.

## Criteria-Mapping Structure

In your appeal letter, address the specific non-formulary or benefit-classification ground Humana cited. If it is a coding error, document the correct procedure code and the applicable benefit category. If it is a coverage determination dispute, argue the procedure falls within the plan's medical/surgical benefit and cite the relevant plan document language. Pair each argument with the supporting documentation.